| 영문 | artificial tears | 한글 | 인공눈물 |
|---|---|---|---|
| 설명 | 자연눈물을 대체하기 위한 액체화합물의 혼합물. 즉, 건조한 눈이나 각막염. 결막염 환자의 눈에 떨어뜨려 사용할 수 있는 다양한 중합체로 된 약물. |
||
| 영문 | immunity | 한글 | 면역 |
|---|---|---|---|
| 설명 | 몸속에 들어온 병원 미생물에 대항하는 항체를 생산하여 독소를 중화하거나 병원 미생물을 죽여서 다음에는 그 병에 걸리지 않도록 된 상태. 또는 그런 작용. 병원성미생물 및 이종단백질, 다당체-지질 등의 침입, 또는 이형 수혈, 조직 이식 등, 폭넓게 자기 이외의 이물이 침입하였을 때 자기를 방위하는 생체반응을 말한다. 원래 일단 감염증에 걸리고 회복되면, 평생 그 병에 걸리지 않는 ‘재발하지 않는 현상’을 의미하였지만, 현재는 사람이나 동물이, 이물의 침입에 대해, 각각 대응한 항체를 생산하여 저항성을 얻는 상태를 말한다. 면역에는 태어나면서부터 갖고 있는 자연면역과, 생후 항원과 접하게 됨에 따라 얻어지는 획득면역이 있으며, 획득면역에는 능동면역과 수동면역이 있다. 능동면역에는 질병 회복 후에 얻어지는 병후 면역과 백신등에 의한 예방접종 결과로 얻어지는 인공적 방법이 있다. 수동면역은 면역항체를 갖는 혈청을 주사해서 얻을 수 있다. |
||
| 영문 | cell-mediated immunity | 한글 | 세포매개면역 |
|---|---|---|---|
| 설명 | 면역이란 신체를 외부의 물질로부터 보호하는 행위를 말한다. 여기에는 특이적 면역과 비특이적 면역의 두 가지가 있다. 비특이적 면역이라함은 특정한 물질에 관계하는 면역이 아니라 특정 대상이 없이 모든 외부 물체에 작용할 수 있는 면역을 말한다. 여기에는 소변의 흐름, 눈물의 흐름, 피부의 비투과성 등의 기계적인 것도 포함되고 피속에 돌아다니는 세포 중에서 비특이적으로 외부의 물질을 포식하는 세포들(예를 들면 큰포식세포(macrophage)의 활동도 포함이 된다. 세포매개면역이란 특이한 물질을 감지할 수 있는 세포를 생성하게 하여 그것으로 하여금 그 물질을 포식하게 하는 것을 말한다. |
||
| AID | 1) Artificial Insemination Donor 2) Donor Artificial Insemination |
|---|---|
| AIH | 1) Artificial Insemination Husband 2) Homologous Artificial Insemination |
| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
| AI | accidental injury; accidentally incurred; adiposity index; aggregation index; allergy and immunology... |
| AIH | amelogenesis imperfecta, hypomaturation type; American Institute of Homeopathy; artificial inseminat... |
| CMI | Cell mediated immunity |
|---|---|
| ACSF | Artificial CSF |
| AID | Artificial Insemination by Donor |
| AI | Artificial Intelligence |
| ANN | Artificial Neural Network |
| artificial active immunity | See: acquired immunity. (05 Mar 2000) |
|---|---|
| artificial passive immunity | See: acquired immunity. (05 Mar 2000) |
| acquired immunity | <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent. These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack. Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction. (13 Nov 1997) |
| active immunity | <immunology> An organisms resistance to disease or infection, developed because the organisms immune system has produced antibodies after an infection or innoculation. (06 May 1997) |
| adoptive immunity | <immunology> Immunity to disease or infection conferred on a previously non-immune individual by transferring lymphocytes from a previously immune individual to the non-immune individual. (15 Jan 1998) |
| allograft immunity | <immunology> The recipient's immune system rejects tissue grafted from a genetically dissimilar donor (of the same species) and stages an immune attack against it. (09 Oct 1997) |
| antiviral immunity | Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever. (05 Mar 2000) |
| bacteriophage immunity | The state induced in a bacterium by lysogenization, the lysogenic bacterium being insusceptible to further lysogenization or to a lytic cycle by a superinfecting bacteriophage, in contradistinction to bacteriophage resistance. (05 Mar 2000) |
| general immunity | Immunity associated with widely diffused mechanisms that tend to protect the body as a whole, as compared with local immunity. (05 Mar 2000) |
| maternal immunity | <epidemiology> Immunity for a neonate provided by IgG antibody generated by a mother and passed across the placenta to the unborn offspring. This provides short lived protection (with a typical half life of 3-6 months) to the neonate. Also known as immunity. (05 Dec 1998) |
| passive immunity | <immunology> Immunity acquired by the transfer from another animal of antibody or sensitised lymphocytes. Passive transfer of antibody from mother to offspring is important for immune defense during the perinatal period. (18 Nov 1997) |
| relative immunity | A modified, not completely effective resistance that results when there is a sort of "fluctuating equilibrium" between the defense mechanisms of the host and the infective agent. (05 Mar 2000) |
| cell-mediated immunity | <immunology> Immune response that involves effector T lymphocytes and not the production of humoral antibody. Responsible for allograft rejection, delayed hypersensitivity and in defence against viral infection and intracellular protozoan parasites. (26 Mar 1998) |
| cellular immunity | <cell biology, immunology> Immune response that involves enhanced activity by phagocytic cells and does not imply lymphocyte involvement. Since the term is easily confused with cell-mediated immunity its use in this sense should be avoided. (26 Mar 1998) |
| cellular immunity deficiency syndrome | <syndrome> A syndrome marked by increased susceptibility to infection, especially to viral infection, associated with defective functioning of the mechanism responsible for acquired immunity of the cell-mediated kind. See: immunodeficiency. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|